Eddi Di Marco
- Microbiology top 5%
- Microbial infections and disease research 4
- Immunology and Allergy top 10%
-
- Polyomavirus and related diseases 2
- Viral-associated cancers and disorders 2
- HER2/EGFR in Cancer Research 2
-
- Cytomegalovirus and herpesvirus research 4
- Rehabilitation top 10%
-
- Gut microbiota and health 4
-
- Neuroblastoma Research and Treatments 3
-
- Autoimmune Bullous Skin Diseases 2
- Co-authors
- Ranieri CanceddaChrister BetsholtzBengt WestermarkGiovanni MelioliM P BeckmannCarl‐Henrik HeldinKeith C. RobbinsStuart A. Aaronson
- Journals
- Science (1 paper)Journal of Biological Chemistry (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- ItalyUnited StatesIran
In The Last Decade
Eddi Di Marco
32 papers receiving 769 citations
Peers
Comparison fields: 5 of 91
- Microbiology 90
- Immunology and Allergy 51
- Oncology 161
- Epidemiology 185
- Rehabilitation 36
Countries citing papers authored by Eddi Di Marco
This map shows the geographic impact of Eddi Di Marco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddi Di Marco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddi Di Marco more than expected).
Fields of papers citing papers by Eddi Di Marco
This network shows the impact of papers produced by Eddi Di Marco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddi Di Marco. The network helps show where Eddi Di Marco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eddi Di Marco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 13 | |
| 7 | 2014 | 10 | |
| 8 | 2013 | 18 | |
| 9 | 2012 | 11 | |
| 10 | 2011 | 9 | |
| 11 | 2011 | 8 | |
| 12 | 2008 | 121 | |
| 13 | 2008 | 26 | |
| 14 | 2006 | 1 | |
| 15 | 2002 | 29 | |
| 16 | 2002 | 3 | |
| 17 | 1992 | 120 | |
| 18 | 1992 | 14 | |
| 19 | 1990 | 69 | |
| 20 | 1986 | 2 |
About Eddi Di Marco
Eddi Di Marco is a scholar working on Microbiology, Pharmacy and Neurology, having authored 34 papers that have together received 783 indexed citations. Recurring topics across this work include Microbial infections and disease research (4 papers), Gut microbiota and health (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Neuroblastoma Research and Treatments (3 papers), Autoimmune Bullous Skin Diseases (2 papers), Polyomavirus and related diseases (2 papers), Viral-associated cancers and disorders (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Microbiology (90 citations), Immunology and Allergy (51 citations) and Oncology (161 citations). Eddi Di Marco has collaborated with scholars based in Italy, United States and Iran. Frequent co-authors include Ranieri Cancedda, Christer Betsholtz, Bengt Westermark, Giovanni Melioli, M P Beckmann, Carl‐Henrik Heldin, Keith C. Robbins, Stuart A. Aaronson, Jacalyn H. Pierce and Pier Paolo Di Fiore. Their work appears in journals such as Science, Journal of Biological Chemistry and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.